Drug wars

Temperatures outside Nomura bank in London climbed into the high summertime registers as six biotech executives in dark suits filed into windowless rooms. The men were immediately segregated into two groups and told they had two days to turn a university spin-out into a billion dollar public company. Oh, and the two groups were competing against each other in a biotech "wargame," and wo

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Temperatures outside Nomura bank in London climbed into the high summertime registers as six biotech executives in dark suits filed into windowless rooms. The men were immediately segregated into two groups and told they had two days to turn a university spin-out into a billion dollar public company. Oh, and the two groups were competing against each other in a biotech "wargame," and would be observed and analyzed by industry experts.

In one room, the executives from the United States took their seats: Bruce Carter, CEO of Zymogenetics; Clive Meanwell, CEO of the Medicines Company; and Tim Rink, retired CEO of Aurora Biosciences Corporation. Sequestered away in another corner of the bank, their British counterparts congregated: Nigel Burns, Chairman of Cell Medica; Eliot Forster, CEO of Solace Pharma; and Neill MacKenzie, co-founder of Oxford BioMedica.

Sponsored by the Bioscience Futures Forum, a government-launched organization run by industry leaders, the wargame ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Megan Scudellari

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio